|
시장보고서
상품코드
2148352
항체 프래그먼트 시장 : 유형별, 유래별, 용도별, 최종사용자별, 지역별Antibody Fragments Market, By Type, By Source, By Application, By End User, By Geography |
||||||
항체 프래그먼트 시장은 2026년에 85억 8,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 128억 9,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.0%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 85억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 6.00% | 2033년 시장 규모 예측 : | 128억 9,000만 달러 |
항체 단편이란, 항원 인식 능력을 유지하면서도 크기가 작고, 조직 침투성이 높으며, 면역원성이 낮다는 장점을 지닌, 설계되었거나 자연적으로 존재하는 완전한 항체의 구성 요소입니다. 주요 단편의 유형로는 Fab, F(ab')2, scFv, 나노바디, 다이아바디 등이 있으며, 이들은 효소 분해나 재조합 기술을 통해 생성되어 치료, 진단, 약물전달, 분자 영상 등의 목적으로 사용됩니다.
전 세계 항체 단편 시장은 바이오의약품 연구의 급증, 만성질환 및 자가면역 질환의 부담 증가, 그리고 생물제제 요법의 이용 확대에 힘입어 성장하고 있습니다. 파지 디스플레이, 효모 디스플레이, 그리고 CRISPR에 기반한 항체 공학의 혁신으로 인해 항체 단편의 설계 및 제조 능력이 확대되고 있으며, 항체 단편은 차세대 정밀 의료 및 표적 치료의 중요한 요소로 자리 잡고 있습니다.
시장 역학
전 세계 항체 단편 시장은 암 및 자가면역 질환의 부담 증가, 표적형 생물제제에 대한 수요 증가, 그리고 파지 디스플레이, 리보솜 디스플레이, CAD(Computer Aided Design)와 같은 항체 공학 기법의 기술적 진보에 힘입어 성장하고 있습니다. 또한 단편을 기반으로 한 이중특이성 항체, ADC(항체-약물 접합체) 및 기타 차세대 생물제제의 개발로 인해 추가적인 연구개발과 상업적 채택이 촉진되고 있습니다.
그러나 항체 단편 시장의 성장은 혈청내 반감기가 짧고, 제조가 복잡하며, 개발 비용이 높고, 엄격한 규제 요건과 같은 요인들로 인해 제약을 받고 있습니다. 그럼에도 불구하고 신흥 시장의 제약 연구개발 확대와 공동 연구에 힘입어 나노바디, 단편을 이용한 분자 영상, 표적 약물전달, 그리고 외주 항체 공학 분야에는 큰 비즈니스 기회가 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 규명하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략)를 바탕으로 전 세계 항체 단편 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서에서 얻은 인사이트를 통해 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- 본 글로벌 항체 단편 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 항체 단편 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활한 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 항체 프래그먼트 시장 : 유형별, 2021-2033년
제5장 세계의 항체 프래그먼트 시장 : 소스별, 2021-2033년
제6장 세계의 항체 프래그먼트 시장 : 용도별, 2021-2033년
제7장 세계의 항체 프래그먼트 시장 : 최종사용자별, 2021-2033년
제8장 세계의 항체 프래그먼트 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
KSA 26.10.19Antibody Fragments Market is estimated to be valued at USD 8.58 Bn in 2026 and is expected to reach USD 12.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.58 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.00% | 2033 Value Projection: | USD 12.89 Bn |
Antibody fragments are designed or naturally occurring parts of complete antibodies that retain antigen recognition capacity but provide advantages including smaller size, increased tissue penetration and decreased immunogenicity. The major types of fragments are Fab, F(ab') 2, scFv, nanobodies and diabodies, which are produced by enzymatic digestion or recombinant techniques for therapeutic, diagnostic, drug-delivery and molecular-imaging purposes.
The global antibody fragments market is driven by a surge in biopharmaceutical research, increasing burden of chronic and autoimmune diseases, and rising use of biologic therapies. Innovations in phage display, yeast display, and CRISPR-based antibody engineering are expanding the design and production capabilities of fragments, making antibody fragments a key element in next-generation precision medicine and targeted treatments.
Market Dynamics
The global antibody fragments market is driven by the increasing burden of cancer and autoimmune diseases, growing demand for targeted biologics, and technological advancements in antibody engineering methods such as phage display, ribosome display, and computational design. Further research and commercial adoption are boosted by the development of fragment-based bispecific, ADCs, and other next-generation biologics.
However, the growth of antibody fragments market is limited by factors such as shorter serum half-life, complex manufacturing, high development cost and stringent regulatory requirement. Nevertheless, significant opportunities exist in nanobodies, fragment-based molecular imaging, targeted drug delivery and outsourced antibody engineering, supported by the growing pharmaceutical R&D and collaborations across the emerging markets.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antibody fragments market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Creative Biolabs Inc., Jackson ImmunoResearch Inc., Rockland Immunochemicals, Inc., SouthernBiotech, Inc., and Absolute Antibody Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global antibody fragments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibody fragments market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Fab / Fab' Fragments
- F(ab')2 Fragments
- scFv
- sdAb / Nanobodies / VHH
- Bispecific and Multispecific Antibody Fragments
- Others
- Source Insights (Revenue, USD Bn, 2021 - 2033)
- Humanized / Recombinant
- Animal-derived / Polyclonal
- Synthetic / Library-derived / Engineered
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Therapeutics
- Diagnostics and Imaging
- Research Reagents
- Drug Delivery and Conjugates
- Biosensors
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Diagnostic Laboratories
- Academic and Research Institutes
- CROs/CDMOs
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Creative Biolabs Inc.
- Jackson ImmunoResearch Inc.
- Rockland Immunochemicals, Inc.
- SouthernBiotech, Inc.
- Absolute Antibody Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Antibody Fragments Market, By Type
- Global Antibody Fragments Market, By Source
- Global Antibody Fragments Market, By Application
- Global Antibody Fragments Market, By End User
- Global Antibody Fragments Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Antibody Fragments Market, By Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Fab / Fab' Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- F(ab')2 Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- scFv
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- sdAb / Nanobodies / VHH
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bispecific and Multispecific Antibody Fragments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Antibody Fragments Market, By Source, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Humanized / Recombinant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Animal-derived / Polyclonal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Synthetic / Library-derived / Engineered
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Antibody Fragments Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnostics and Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Drug Delivery and Conjugates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Biosensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Antibody Fragments Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- CROs/CDMOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Antibody Fragments Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Techne Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Creative Biolabs Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jackson ImmunoResearch Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rockland Immunochemicals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SouthernBiotech, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Absolute Antibody Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
